Zanubrutinib

Back to search

Molecule Structure

Scientific Name

Zanubrutinib

Description of the Drug

Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15035

Brand Name(s)

Brukinsa

Company Owner(s)

Beigene Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tyrosine-protein kinase BTK SINGLE PROTEIN INHIBITOR CHEMBL5251

Unichem Links

SureChEMBL SCHEMBL17842597
Human Metabolome Database HMDB0304875
DrugBank DB15035
PubChem 135565884
BindingDB 250082
DrugCentral 5353
ChemicalBook CB93361383
rxnorm BRUKINSA ZANUBRUTINIB
ZINC ZINC000584641430